Seres Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.09.24	Seres Therapeutics Stockholders Approve Sale Of VOWST Business To Societe Des Produits Nestle (RTTNews)
06.06.24	Seres Therapeutics Signs MoU For Sale Of Its VOWST Assets To Nestle Health Science (RTTNews)
26.02.24	Seres Therapeutics Appoints Marella Thorell As New CFO Following Retirement Of David Arkowitz (RTTNews)
09.01.24	Seres Therapeutics Issues VOWST Commercial Update; Gets Fast Track Designation For SER-155 (RTTNews)
21.11.23	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics (PR Newswire)
01.11.23	Flagship Pioneering Launches Pioneering Intelligence (PR Newswire)
11.09.23	Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer (PR Newswire)
31.03.23	Biotech Stocks Facing FDA Decision In April 2023 (RTTNews)
07.09.22	Seres Completes Rolling BLA Submission To FDA For SER-109 For Prevention Of RCDI (RTTNews)
30.06.22	Seres Therapeutics Announces $100 Mln Direct Offering Of Stock (RTTNews)
15.02.22	INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT (PR Newswire)
05.01.22	Pre-market Movers: MYNZ, WEJO, ANNX, ARAV, SENS… (RTTNews)
13.10.21	Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change (PR Newswire)
03.10.21	Seres : Phase 3 Study Shows SER-109 Associated With Reduction Of ARGs In Patients With Recurrent CDI (RTTNews)
22.07.21	Seres Therapeutics : Phase 2b Study On Ulcerative Colitis Fails To Meet Main Goal; Stock Plunges (RTTNews)
15.06.21	Dr. Stephen Hahn, 24th US FDA Commissioner and Former Chief Medical Executive at MD Anderson, joins Flagship Pioneering as Chief Medical Officer of Flagship's Preemptive Medicine and Health Securi... (PR Newswire)
01.06.21	Seres Announces FDA Clearance Of IND For SER-155 (RTTNews)
01.06.21	Seres Therapeutics Announces FDA Clearance Of IND For SER-155 (RTTNews)
11.08.20	CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs (RTTNews)
10.08.20	Stock Alert: Seres Therapeutics Soars 300% On Positive Data From Trial Of Colon Infection Drug (RTTNews)
12.03.19	8 Top Gainers In Healthcare Sector (BPTH, ORGO, PTE...) (RTTNews)
04.10.18	PTIE Soars 200%, RTRX On Track, All Eyes On EVFM, MCRB (RTTNews)
28.11.17	CDNA, ALNA Up On Analyst Coverage, LIFE Goes Ahead, GLYC Gearing Up For ASH (RTTNews)
14.11.17	Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team (PR Newswire)
01.11.17	Sigilon Therapeutics Appoints Eric Shaff to Board of Directors (PR Newswire)
03.10.17	ECYT On Fire After ABX Deal, Rigel's ITP Drug Skips Panel Review, MCRB On Watch (RTTNews)
21.07.17	Gainers & Losers Of July 20: SRPT, AKCA, AGRX, INO, IRWD... (RTTNews)
19.07.17	Gainers & Losers Of July 18: CAPR, NVAX, TTOO, IMUC, SBPH... (RTTNews)
13.06.17	XLRN's DART Misses Mark, RGLS Makes Cuts In Pipeline, FDA Snubs CHRS (RTTNews)
17.03.17	Gainers & Losers Of Mar.16: MCRB, PLSE, OCUL, PTCT, TROV... (RTTNews)
31.01.17	AEZS Inches Closer To D-Day, EYEG Catches Investors' Eyes, MCRB On Watch (RTTNews)
15.12.16	Flagship Ventures Evolves Name To Flagship Pioneering (PR Newswire)
23.11.16	Biotech Stocks Under Scanner -- PTC Therapeutics, Arena Pharma, BioDelivery Sciences, and Seres Therapeutics (PR Newswire)
01.08.16	TKAI Laying Off Staff Big Time, MCRB Plunges, FDA Says No To ADMA (RTTNews)
11.01.16	Seres Announces Collaboration With Nestlé Health Science - Quick Facts (RTTNews)
15.12.15	APDN Up On Revenue Growth, ATRA Pulls Plug On Kidney Drug, NEOT Falls Flat (RTTNews)
24.08.15	VTL Plunges As Trial Flops, NWBO Sets It Straight, Court Rules In Favor Of MDXG (RTTNews)
21.08.15	Seres Therapeutics Announces FDA Orphan Drug Designation For SER-109 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Seres Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten